ATE308497T1 - Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen - Google Patents
Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchenInfo
- Publication number
- ATE308497T1 ATE308497T1 AT97920694T AT97920694T ATE308497T1 AT E308497 T1 ATE308497 T1 AT E308497T1 AT 97920694 T AT97920694 T AT 97920694T AT 97920694 T AT97920694 T AT 97920694T AT E308497 T1 ATE308497 T1 AT E308497T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- cyclin
- interaction
- estrogen receptor
- trials
- Prior art date
Links
- 102100038595 Estrogen receptor Human genes 0.000 title abstract 2
- 108010038795 estrogen receptors Proteins 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 title abstract 2
- 108050006400 Cyclin Proteins 0.000 title 1
- 102100036691 Proliferating cell nuclear antigen Human genes 0.000 title 1
- 229940011871 estrogen Drugs 0.000 abstract 2
- 239000000262 estrogen Substances 0.000 abstract 2
- 238000005462 in vivo assay Methods 0.000 abstract 2
- 108010058546 Cyclin D1 Proteins 0.000 abstract 1
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000000099 in vitro assay Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9608143.5A GB9608143D0 (en) | 1996-04-19 | 1996-04-19 | Assay |
| PCT/EP1997/001888 WO1997040378A1 (en) | 1996-04-19 | 1997-04-16 | Interaction of cyclin d1 and estrogen receptor and its use in assays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE308497T1 true ATE308497T1 (de) | 2001-11-15 |
Family
ID=10792355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97920694T ATE308497T1 (de) | 1996-04-19 | 1997-04-16 | Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6033843A (de) |
| EP (1) | EP0898708B1 (de) |
| JP (1) | JP2000508777A (de) |
| AT (1) | ATE308497T1 (de) |
| AU (1) | AU2698197A (de) |
| CA (1) | CA2249396A1 (de) |
| DE (1) | DE69708081T2 (de) |
| DK (1) | DK0898708T3 (de) |
| GB (1) | GB9608143D0 (de) |
| WO (1) | WO1997040378A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1021462A4 (de) * | 1997-10-07 | 2005-04-13 | Merck & Co Inc | Test für kernrezeptor-liganden unter verwendung von fret |
| JP2002503811A (ja) | 1998-02-12 | 2002-02-05 | プロリフィクス リミテッド | サイクリンｄ１とステロイド受容体コアクチベーターとの相互作用、およびアッセイにおけるその使用 |
| US6210924B1 (en) * | 1998-08-11 | 2001-04-03 | Amgen Inc. | Overexpressing cyclin D 1 in a eukaryotic cell line |
| WO2001059448A1 (fr) * | 2000-02-10 | 2001-08-16 | Chugai Seiyaku Kabushiki Kaisha | Procede de criblage d'un agent antiandrogene |
| EP1167975B1 (de) * | 2000-06-22 | 2009-10-07 | Universite Paris Descartes | Zusammensetzungen und Methoden zum Nachweis, Behandeln oder Vorhersagen der Antwort von Brust Tumorzellen auf eine Endocrin-Therapie |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ257181A (en) * | 1992-10-29 | 1997-07-27 | Medical Res Council | Transcription factor dp-1, dna, vectors and host cells therefor |
-
1996
- 1996-04-19 GB GBGB9608143.5A patent/GB9608143D0/en active Pending
-
1997
- 1997-04-16 DE DE69708081T patent/DE69708081T2/de not_active Expired - Fee Related
- 1997-04-16 AT AT97920694T patent/ATE308497T1/de not_active IP Right Cessation
- 1997-04-16 WO PCT/EP1997/001888 patent/WO1997040378A1/en not_active Ceased
- 1997-04-16 AU AU26981/97A patent/AU2698197A/en not_active Abandoned
- 1997-04-16 DK DK97920694T patent/DK0898708T3/da active
- 1997-04-16 CA CA002249396A patent/CA2249396A1/en not_active Abandoned
- 1997-04-16 JP JP9537692A patent/JP2000508777A/ja not_active Ceased
- 1997-04-16 US US09/171,151 patent/US6033843A/en not_active Expired - Fee Related
- 1997-04-16 EP EP97920694A patent/EP0898708B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6033843A (en) | 2000-03-07 |
| JP2000508777A (ja) | 2000-07-11 |
| GB9608143D0 (en) | 1996-06-26 |
| DK0898708T3 (da) | 2002-03-04 |
| AU2698197A (en) | 1997-11-12 |
| CA2249396A1 (en) | 1997-10-30 |
| EP0898708A1 (de) | 1999-03-03 |
| WO1997040378A1 (en) | 1997-10-30 |
| DE69708081T2 (de) | 2002-07-04 |
| EP0898708B1 (de) | 2001-11-07 |
| DE69708081D1 (de) | 2001-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69632949D1 (de) | Die aktivierung von rezeptoren durch gas6 | |
| DE69830404D1 (de) | P38-inhibitoren | |
| TR200003513T2 (tr) | Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları | |
| ATE517125T1 (de) | ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN | |
| BR0308339A (pt) | Indazóis substituìdos com uma atividade anticancerosa | |
| DE60131430D1 (de) | Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion | |
| Kanafi et al. | Influence of hypoxia, high glucose, and low serum on the growth kinetics of mesenchymal stem cells from deciduous and permanent teeth | |
| AR018023A1 (es) | Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada | |
| DE69825066D1 (de) | Veränderte proteinkinasen, die modifizierte nukleotidtriphosphat substrate verwenden können | |
| ATE309378T1 (de) | Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung | |
| PT1379671E (pt) | Métodos de cultura de circovírus | |
| DK0701604T3 (da) | Immortalisering af dendritiske celler med V-myc-onkogenet | |
| ATE308497T1 (de) | Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen | |
| DE69631972D1 (de) | Proliferationsinhibitor von endothellzellen und dessen verwendung | |
| TR200201459T2 (tr) | Okzkarbazepin içeren süspansiyon | |
| ATE400654T1 (de) | Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehört | |
| FR2842822B1 (fr) | Procede de preparation d'une matrice extracellulaire et son utilisation pour la culture de cellules tumorales | |
| Smadja et al. | PAR‐1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood | |
| ATE274351T1 (de) | Verwendung von isolierten domänen des type-iv- kollagens zur änderung der zell- und gewebewechselwirkung | |
| ATE309332T1 (de) | Unsterbliche retinalzellinien und deren anwendungen | |
| FR2776188B1 (fr) | Oleamide de glycylglycine en dermo-cosmetologie | |
| DE59508100D1 (de) | Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander | |
| Lefor et al. | Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model | |
| BR0013221A (pt) | Chá preto de folha | |
| TR200003695T2 (tr) | Anjiyostatin bağlayıcı protein. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |